Paolo Bonfanti

Summary

Affiliation: University of Milan
Country: Italy

Publications

  1. ncbi Is metabolic syndrome associated to HIV infection per se? Results from the HERMES study
    Paolo Bonfanti
    Department of Infectious Diseases, Luigi Sacco Hospital, Via G B Grassi, 44, 20157 Milano, Italy
    Curr HIV Res 8:165-71. 2010
  2. doi The feature of Metabolic Syndrome in HIV naive patients is not the same of those treated: results from a prospective study
    Paolo Bonfanti
    Department of Infectious Diseases, A Manzoni Hospital, Via Dell Eremo 9, Lecco, Italy
    Biomed Pharmacother 66:348-53. 2012
  3. ncbi Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project
    Giordano Madeddu
    Department of Infectious Diseases, University of Sassari, Via De Nicola 1, Sassari, Italy
    Biomed Pharmacother 62:6-11. 2008
  4. doi Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: results from the SIMONE study
    Giuseppe Vittorio L De Socio
    Department of Infectious Diseases, Santa Maria Hospital, Perugia, Italy
    J Infect 57:33-40. 2008
  5. ncbi HIV and metabolic syndrome: a comparison with the general population
    Paolo Bonfanti
    Department of Infectious Diseases, Luigi Sacco Hospital, Via G B Grassi 44, 20157 Milan, Italy
    J Acquir Immune Defic Syndr 45:426-31. 2007
  6. doi Decreasing cardiovascular risk in HIV infection between 2005 and 2011
    Giuseppe V De Socio
    aDepartment of Infectious Diseases, Azienda Ospedaliero Universitaria di Perugia, Perugia bDepartment of Infectious Diseases, Pescara Hospital, Pescara cDepartment of Infectious Diseases, Luigi Sacco Hospital, Milan dDepartment of Infectious Diseases, University of Bari, Bari eDepartment of Infectious Diseases, Garibaldi Hospital, University of Catania, Catania fDepartment of Infectious Diseases, Galliera Hospital, Genoa, Genoa gDepartment of Infectious Diseases, Careggi Hospital, Florence hDepartment of Infectious Diseases, University of Milan, Milan iDepartment of Infectious Diseases, San Martino Hospital Genoa, University of Genoa, Genoa jDepartment of Infectious Diseases, Manzoni Hospital, Lecco kUniversitĂ  di Perugia and Struttura Complessa di Medicina Interna, Azienda Ospedaliero Universitaria di Terni, Terni, Italy
    AIDS 28:609-12. 2014
  7. doi The burden of metabolic diseases amongst HIV positive patients on HAART attending The Johannesburg Hospital
    Henry Julius
    Department of Infectious Disease, Azienda Ospendaliera di Lecco, Italy
    Curr HIV Res 9:247-52. 2011
  8. doi The cost of HIV disease in Northern Italy: the payer's perspective
    Giuliano Rizzardini
    First Infectious Diseases Department, Luigi Sacco Hospital, Milan, Italy
    J Acquir Immune Defic Syndr 57:211-7. 2011
  9. doi Secondary hyperparathyroidism in HIV patients: is there any responsibility of highly active antiretroviral therapy?
    Daria Pocaterra
    Department of Infectious Diseases, Luigi Sacco Hospital, Milan, Italy
    AIDS 25:1430-3. 2011
  10. ncbi An Italian approach to postmarketing monitoring: preliminary results from the SCOLTA (Surveillance Cohort Long-Term Toxicity Antiretrovirals) project on the safety of lopinavir/ritonavir
    Paolo Bonfanti
    Department of Infectious Diseases, Luigi Sacco Hospital, Milan, Italy
    J Acquir Immune Defic Syndr 39:317-20. 2005

Collaborators

Detail Information

Publications12

  1. ncbi Is metabolic syndrome associated to HIV infection per se? Results from the HERMES study
    Paolo Bonfanti
    Department of Infectious Diseases, Luigi Sacco Hospital, Via G B Grassi, 44, 20157 Milano, Italy
    Curr HIV Res 8:165-71. 2010
    ..These findings of the HERMES study suggest, therefore, that HIV infection per se is associated to MS...
  2. doi The feature of Metabolic Syndrome in HIV naive patients is not the same of those treated: results from a prospective study
    Paolo Bonfanti
    Department of Infectious Diseases, A Manzoni Hospital, Via Dell Eremo 9, Lecco, Italy
    Biomed Pharmacother 66:348-53. 2012
    ..However, the feature of MS was different in the two groups, suggesting that in untreated and treated patients MS developed through different metabolic pathways...
  3. ncbi Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project
    Giordano Madeddu
    Department of Infectious Diseases, University of Sassari, Via De Nicola 1, Sassari, Italy
    Biomed Pharmacother 62:6-11. 2008
    ..To evaluate the prevalence and incidence of nephrotoxicity in HIV-infected patients enrolled in the SCOLTA Project tenofovir cohort and to identify possible risk factors...
  4. doi Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: results from the SIMONE study
    Giuseppe Vittorio L De Socio
    Department of Infectious Diseases, Santa Maria Hospital, Perugia, Italy
    J Infect 57:33-40. 2008
    ..To identify and characterize HIV-infected patients at higher cardiovascular risk in ordinary clinical settings...
  5. ncbi HIV and metabolic syndrome: a comparison with the general population
    Paolo Bonfanti
    Department of Infectious Diseases, Luigi Sacco Hospital, Via G B Grassi 44, 20157 Milan, Italy
    J Acquir Immune Defic Syndr 45:426-31. 2007
    ..To compare the prevalence of metabolic syndrome (MS) in HIV-positive patients with that from a sample of a general Italian population...
  6. doi Decreasing cardiovascular risk in HIV infection between 2005 and 2011
    Giuseppe V De Socio
    aDepartment of Infectious Diseases, Azienda Ospedaliero Universitaria di Perugia, Perugia bDepartment of Infectious Diseases, Pescara Hospital, Pescara cDepartment of Infectious Diseases, Luigi Sacco Hospital, Milan dDepartment of Infectious Diseases, University of Bari, Bari eDepartment of Infectious Diseases, Garibaldi Hospital, University of Catania, Catania fDepartment of Infectious Diseases, Galliera Hospital, Genoa, Genoa gDepartment of Infectious Diseases, Careggi Hospital, Florence hDepartment of Infectious Diseases, University of Milan, Milan iDepartment of Infectious Diseases, San Martino Hospital Genoa, University of Genoa, Genoa jDepartment of Infectious Diseases, Manzoni Hospital, Lecco kUniversitĂ  di Perugia and Struttura Complessa di Medicina Interna, Azienda Ospedaliero Universitaria di Terni, Terni, Italy
    AIDS 28:609-12. 2014
    ..3% vs. 33.4% (P = 0.006). Blood glucose, triglycerides, prevalence of smokers, and lipodystrophy were all significantly lower in 2011 (all P < 0.0001). Cardiovascular risk improved over a 6-year period in Italian HIV-infected patients...
  7. doi The burden of metabolic diseases amongst HIV positive patients on HAART attending The Johannesburg Hospital
    Henry Julius
    Department of Infectious Disease, Azienda Ospendaliera di Lecco, Italy
    Curr HIV Res 9:247-52. 2011
    ..Further studies are needed in order to survey a population where HIV infection is turning into a chronic disease, with its complications...
  8. doi The cost of HIV disease in Northern Italy: the payer's perspective
    Giuliano Rizzardini
    First Infectious Diseases Department, Luigi Sacco Hospital, Milan, Italy
    J Acquir Immune Defic Syndr 57:211-7. 2011
    ..Healthcare expenditures incurred by the Health Service for HIV-infected patients have not been reported in Italy...
  9. doi Secondary hyperparathyroidism in HIV patients: is there any responsibility of highly active antiretroviral therapy?
    Daria Pocaterra
    Department of Infectious Diseases, Luigi Sacco Hospital, Milan, Italy
    AIDS 25:1430-3. 2011
    ..This high prevalence (17.5%) was in part justified by the high prevalence of hypovitaminosis D (77.4%) in the whole sample, but we also identified an independent association with the use of tenofovir...
  10. ncbi An Italian approach to postmarketing monitoring: preliminary results from the SCOLTA (Surveillance Cohort Long-Term Toxicity Antiretrovirals) project on the safety of lopinavir/ritonavir
    Paolo Bonfanti
    Department of Infectious Diseases, Luigi Sacco Hospital, Milan, Italy
    J Acquir Immune Defic Syndr 39:317-20. 2005
    ..These findings, though preliminary, show that this data collection method gives timely real-life information from which to assess the impact of short- and long-term toxicity of new antiretroviral drugs...
  11. ncbi Bilateral carotid stenosis in a young female HIV patient treated with highly active antiretroviral therapy
    Simona Landonio
    Department of Infectious Diseases, Luigi Sacco Hospital, Milan, Italy
    AIDS 16:2225-7. 2002
  12. ncbi Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop
    Giampiero Carosi
    Department of Infectious Disease, University of Brescia, Brescia, Italy
    AIDS Rev 7:161-7. 2005
    ....